Overall, our results point to a key role of VDAC1 in activating the molecular cascade leading to the mitochondrial dysfunction in AD and provide new insights for the development of a pharmacological therapy based on VDAC1 modulation. The gene discussed is VDAC1; the disease is Alzheimer disease.